We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)

This study has suspended participant recruitment.
(lack of new patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00832403
First Posted: January 30, 2009
Last Update Posted: January 30, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hospital Felicio Rocho
January 27, 2009
January 30, 2009
January 30, 2009
November 2006
February 2008   (Final data collection date for primary outcome measure)
improvement of fetid crusts and atrophy of the mucous bone covering [ Time Frame: after surgery recovery ]
Same as current
No Changes Posted
lack of side effects such as infection [ Time Frame: after the treatment ]
Same as current
Not Provided
Not Provided
 
Gore Tex Implants in the Treatment of Atrophic Rhinitis
Gore Tex Implants in the Treatment of Atrophic Rhinitis

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Patients that were submit to surgery to treat atrophic rhinitis with implants in the nasal fossa.
Atrophic Rhinitis
Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa
polytetrafluoroethylene
Intervention: Other: implants of polytetrafluoroethylene in tha nasal fossa
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
5
Not Provided
February 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria:

  • Patients with mental illness
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00832403
Rinite Atrófica cep/hfr
No
Not Provided
Not Provided
Larissa Oliveira Lauriano, Hospital Felício Rocho
Hospital Felicio Rocho
Not Provided
Not Provided
Hospital Felicio Rocho
January 2009